QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Cancer nanomedicine meets immunotherapy: opportunities and challenges 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 7, 页码: 954-958 作者:  Sun, Qingxue;  Bai, Xiangyang;  Sofias, Alexandros Marios;  van der Meel, Roy;  Ruiz-Hernandez, Eduardo 收藏  |  浏览/下载：12/0  |  提交时间：2020/12/24 nanomedicine  immunotherapy  targeting  combination therapy  clinical translation   Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography-tandem mass spectrometry 期刊论文 DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13, 页码: 1739-1749 作者:  Li, Junling;  Li, Wei;  Dai, Xiaojian;  Zhong, Dafang;  Ding, Yaping 收藏  |  浏览/下载：5/0  |  提交时间：2020/07/01 nab-paclitaxel  bioequivalence  rapid equilibrium dialysis  unbound fraction  pharmacokinetics   Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer 期刊论文 ONCOTARGETS AND THERAPY, 2016, 卷号: 9, 页码: 5693-5698 作者:  Ai, Dan;  Guan, Yan;  Liu, Xiu-Ju;  Zhang, Chu-Feng;  Wang, Peng 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/16 cisplatin  Abraxane  gemcitabine  advanced non-small-cell lung cancer  chemotherapy   Abraxane (R) versus Taxol (R) for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective 期刊论文 JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 卷号: 22, 期号: 2 作者:  Dranitsaris, George;  Yu, Bo;  Wang, Leiping;  Sun, Weili;  Zhou, Yan 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/06 Abraxane (R)  paclitaxel  metastatic breast cancer  resource use  cost analysis   Abraxane (R) versus Taxol (R) for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective 期刊论文 2016, 卷号: 22, 期号: 2, 页码: 205-211 作者:  Dranitsaris, George;  Yu, Bo;  Wang, Leiping;  Sun, Weili;  Zhou, Yan 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 Abraxane (R)  paclitaxel  metastatic breast cancer  resource use  cost analysis